Global, Multicenter Study of AMT-116 Versus Investigator's Choice in Participants With Advanced or Metastatic Non-squamous EGFR-Wildtype Non-Small Cell Lung Cancer (NSCLC) With Progression on or After Platinum-Based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy
PHASE2
This clinical trial consists of two parts: phase 2 and phase 3.
The goal o...
Status
Not Yet Recruiting
Location
Hematology Oncology Associates of the Treasure Coast